WST
West Pharmaceutical Services Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
West Pharmaceutical Services Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Largest filed tie
15.80%
of WST revenue · one of these customers
Last report4 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+3.23%
vs ±8.3% implied · ×0.39
shaded = implied · ▲▼ = realized
No thesis.
West Pharmaceutical Services Inc
412.42
−4.25 · −1.02%
post 412.41 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $2.4B | 9.46% | −2.70% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $1.7B | 6.56% | −1.50% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.4B | 5.71% | −1.91% | |
| 4 | FMRFMR | $1.3B | 5.08% | +186.04% | |
| 5 | State StreetState Streetindex-like | $1.2B | 4.76% | +1.67% | |
| 6 | Artisan Partners Limited PartnershipArtisan Partners Limited Partnership | $865.8M | 3.43% | −9.26% | |
| 7 | Bank of New York MellonBank of New York Mellonindex-like | $733.7M | 2.91% | −17.12% | |
| 8 | Generation Investment ManagementGeneration | $728.2M | 2.88% | −9.61% | |
| 9 | Geode Capital ManagementGeodeindex-like | $680.6M | 2.70% | −0.48% | |
| 10 | T. Rowe Price Investment ManagementT. Rowe Price | $648.0M | 2.57% | −22.88% | |
| 11 | Morgan StanleyMorgan Stanley | $568.1M | 2.25% | +8.52% | |
| 12 | JPMorgan ChaseJPMorgan Chase | $413.0M | 1.64% | new | |
| 13 | Brown AdvisoryBrown Advisory | $386.0M | 1.53% | −19.81% | |
| 14 | Longview Partners (Guernsey)Longview Partners (Guernsey) | $371.1M | 1.47% | −21.41% | |
| 15 | InvescoInvesco | $362.5M | 1.44% | new | |
| 16 | UBS Asset Management AmericasUBS Asset Management Americas | $317.7M | 1.26% | −1.98% | |
| 17 | Norges BankNorges Bankindex-like | $309.8M | 1.23% | — | |
| 18 | Goldman Sachs GroupGoldman Sachs | $292.5M | 1.16% | +11.98% | |
| 19 | Kayne Anderson Rudnick Investment ManagementKayne Anderson Rudnick | $273.1M | 1.08% | −11.38% | |
| 20 | TD Asset ManagementTD Asset Management | $262.4M | 1.04% | −4.93% | |
| 21 | Northern TrustNorthern Trustindex-like | $254.7M | 1.01% | −2.99% | |
| 22 | Capital Research Global InvestorsCapital Research Global Investors | $218.7M | 0.87% | +0.86% | |
| 23 | VAN ECK AssociatesVAN ECK | $217.1M | 0.86% | −15.25% | |
| 24 | ProShare AdvisorsProShare | $214.7M | 0.85% | −9.40% | |
| 25 | Findlay Park PartnersFindlay Park Partners | $214.2M | 0.85% | −3.26% |
829 managers report $25.3B of West Pharmaceutical Services on form 13F for the quarter ended Jun 30 '26. 51 of them hold 80% of it; BlackRock is largest at 9.46%.
No implied move.
No implied move.
Expected move
No implied move.